As of 2026-09-16, the Fair Value of Altimmune Inc (ALT) is -2.36 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.23 USD, the upside of Altimmune Inc is -173.04%.
With the market price of 3.23 USD and our fair value calculation, Altimmune Inc (ALT) is not a good investment. Investing in Altimmune stocks now will result in a potential loss of 173.04%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -97.09 | -84.71 | -88.45 | -95.06 | -88.09 | -90.68 |
| YoY growth | -97.98% | 12.75% | -4.41% | -7.48% | 7.33% | -17.96% |
| Market Cap (mil) | 628.14 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | -17.96% |
| TTM earnings | -91.76 |